Recent Updates
Recently added Catalysts
ATHE

Appendix 4C Quarterly Report for Entities Admitted on the Basis of Commitments Rule 4.7B Appendix 4C - 3 rd Quarter Quarterly report for entities admitted on the basis of commitments Introduced 31/3/2000. Amended 30/9/20

Thursday, April 30, 2009 1 min read
Key Takeaway: Appendix 4C Quarterly Report for Entities Admitted on the Basis of Commitments Rule 4.7B the basis of commitments 31/3/2000. Amended 30/9/2001 Name of Entity: PRANA BIOTECHNOLOGY LIMITED ABN: Quarter Ended ('Current Quarter') 37 080 699 065 31 st March, 2009 Statement of

Full Press Release Details

Appendix 4C Quarterly Report for Entities Admitted on the Basis of Commitments
Rule 4.7B
the basis of commitments
31/3/2000. Amended 30/9/2001
Name of Entity:
PRANA BIOTECHNOLOGY LIMITED
ABN: Quarter Ended ('Current Quarter')
37 080 699 065 31 st March, 2009
Statement of Cash Flows
Cash Flows Related to Operating Activities Current Quarter $A'000 Year to Date (9 months) $A'000
1.1 Receipts from customers - -
1.2 Payments for (a) staff costs (b) advertising and marketing (c) research and development (d) leased assets (e) other working capital (365) (7) (1,228) - (487) (1,190) (24) (3,393) - (1,717)
1.3 Dividends received - -
1.4 Interest and other items of a similar nature received 63 484
1.5 Interest and other costs of finance paid - -
1.6 Income taxes paid - -
1.7 Other (GST on grant income)* - 309
Net Operating Cash Flows (2,024) (5,531)
+ See chapter 19 for defined terms.
30/9/2001 Appendix 4C Page 1
Current Quarter $A'000 Year to Date (9 months) $A'000
1.8 Net Operating Cash Flows (carried forward) (2,024) (5,531)
- -
Cash Flows Related to Investing Activities
1.9 Payment for acquisition of: (a) businesses (item 5) (b) equity investments (c) intellectual property (d) physical non-current assets (e) other non-current assets - - - (4) - - - - (36) -
1.10 Proceeds from disposal of: (a) businesses (item 5) (b) equity investments (c) intellectual property (d) physical non-current assets (e) other non-current assets - - - - - - - - - -
1.11 Loans to other entities - -
1.12 Loans repaid by other entities - -
1.13 Other (Foreign Currency bond refund) 11 11
Net Investing Cash Flows 7 (25)
1.14 Total Operating and Investing Cash Flows (2,017) (5,556)
Cash Flows Related to Financing Activities
1.15 Proceeds from issues of shares, options, etc. - 114
1.16 Proceeds from sale of forfeited shares - -
1.17 Proceeds from borrowings - -
1.18 Repayment of borrowings - -
1.19 Dividends paid - -
1.20 Other (Capital Raising Costs) (4) (12)
Net Financing Cash Flows (4) 102
Net Increase / (Decrease) in Cash Held (2,021) (5,454)
1.21 Cash at beginning of quarter/year to date 7,852 11,219
1.22 Exchange rate adjustments to item 1.20 (9) 57
1.23 Cash at End of Quarter 5,822 5,822
+ See chapter 19 for defined terms.
Appendix 4C Page 2 30/9/2001
to Directors of the Entity and Associates of the Directors
to Related Entities of the Entity and Associates of the Related
Current Quarter $A'000
1.24 Aggregate amount of payments to the parties included in item 1.2 104
1.25 Aggregate amount of loans to the parties included in item 1.11
1.26 Explanation necessary for an understanding of the transactions
Salaries, directors' fees and consulting fees at normal commercial rates.
Financing and Investing Activities
2.1 Details of financing and investing transactions which have had a material effect on consolidated assets and liabilities but did not involve cash flows
During the period 31,250 shares were issued to consultants in lieu of services rendered.
2.2 Details of outlays made by other entities to establish or increase their share in businesses in which the reporting entity has an interest
-
Facilities Available
notes as necessary for an understanding of the position. (See AASB 1026
Amount Available $A'000 Amount Used $A'000
3.1 Loan facilities - -
3.2 Credit standby arrangements - -
+ See chapter 19 for defined terms.
30/9/2001 Appendix 4C Page 3
Reconciliation of cash at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts is as follows. Current Quarter $A'000 Previous Quarter $A'000
4.1 Cash on hand and at bank 5,822 7,852
4.2 Deposits at call - -
4.3 Bank overdraft - -
4.4 Other (provide details) - -
Total: Cash at End of Quarter (item 1.22) 5,822 7,852
and Disposals of Business Entities
Acquisitions (Item 1.9(a)) Disposals (Item 1.10(a))
5.1 Name of entity - -
5.2 Place of incorporation or registration - -
5.3 Consideration for acquisition or disposal - -
5.4 Total net assets - -
5.5 Nature of business - -
Company Secretary
Print Name: Richard Revelins
+ See chapter 19 for defined terms.
Appendix 4C Page 4 30/9/2001
9.4 - itemised disclosure relating to disposals
12.1(a) - policy for classification of cash items
+ See chapter 19 for defined terms.
30/9/2001 Appendix 4C Page 5
Tags: ATHE Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Apr 30, 2009